Shots:

• The US FDA has granted the Breakthrough Device designation to the Avantis platform for restoring movement. Avantis device delivers small electrical impulses to the spinal cord to restore shoulder, arm & hand movement in individuals with impairment due to chronic stroke
• Recently published findings showed 40% & 108% improvements in grip strength in the first 2 study participants, and ~124% improvement in joint strength, participants successfully performed functional tasks
• Improvements were retained ~1mos. after the study even without stimulation. The company develops implantable neuromodulation systems to help patients recover upper limb motor function after a chronic stroke & other neurological conditions

Ref: PRNewswire | Image: Reach Neuro